High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

Overview of attention for article published in Journal of Hematology & Oncology, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 21,030 followers.

RT @ACortelliniMD: Out on JHON @BioMedCentral!It's been super hard putting this together. Could family history of cancer be associated with…

RT @ACortelliniMD: Out on JHON @BioMedCentral!It's been super hard putting this together. Could family history of cancer be associated with…

RT @ACortelliniMD: Out on JHON @BioMedCentral!It's been super hard putting this together. Could family history of cancer be associated with…

RT @ACortelliniMD: Out on JHON @BioMedCentral!It's been super hard putting this together. Could family history of cancer be associated with…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.